Both in Pharmaceuticals
CNS Pharmaceuticals vs Enveric Biosciences
Over the past year CNSP returned −41.4% and ENVB returned −78.7%; their daily moves had a correlation of -0.02.
CNSP −41.4% ENVB −78.7%Growth of $1, one year, split-adjusted
| Metric | CNSP | ENVB |
|---|---|---|
| Price | $4.45 | $1.43 |
| Market cap | $6.5M | $6.4M |
| Today | −6.71% | −2.05% |
| 1 month | −15.1% | −2.1% |
| 6 months | +92.5% | −64.2% |
| Year to date | −15.2% | −60.6% |
| 1 year | — | −78.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $20.0M | $8.3M |
| Dividend yield | — | — |
| Volatility (60d) | 69.3% | 48.0% |
| Short % of float | 0.1% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).